Akero Therapeutics (AKRO) Tops Q1 EPS by 11c
Akero Therapeutics (NASDAQ: AKRO) reported Q1 EPS of ($0.90), $0.11 better than the analyst estimate of ($1.01).
For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.
Akero Therapeutics (NASDAQ: AKRO) reported Q1 EPS of ($0.90), $0.11 better than the analyst estimate of ($1.01).
For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.